UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2022 | 2022-02-03 | Future report Set alerts | |
| Q4 2021 | 2021-11-05 | 1.67 | 1.67 |
| Q3 2021 | 2021-07-30 | 1.38 | 1.38 |
| Q2 2021 | 2021-04-30 | 1.73 | 1.73 |
| Q1 2021 | 2021-02-05 | 1.53 | 1.53 |
| Q4 2020 | 2020-11-06 | 0.00 | 0.00 |
| Q3 2020 | 2020-07-31 | 1.95 | 1.40 |
| Q2 2020 | 2020-05-01 | 1.28 | 0.70 |
| Q1 2020 | 2020-01-24 | 1.13 | 0.59 |
| Q4 2019 | 2019-11-01 | 1.69 | 0.41 |
| 2016-06-23 | Reiterated Rating | KeyBanc | Buy | $59.00 |
| 2016-06-23 | Reiterated Rating | KeyCorp | Buy | $59.00 |
| 2016-06-16 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $54.00 to $62.00 |
| 2016-05-03 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-05-02 | Reiterated Rating | Bank of America | Buy | $69.00 |
| 2016-05-02 | Reiterated Rating | Bank of America Corp. | Buy | $69.00 |
| 2016-04-08 | Boost Price Target | Goldman Sachs | $52.00 to $55.00 | |
| 2016-04-08 | Boost Price Target | Goldman Sachs Group Inc. | $52.00 to $55.00 | |
| 2016-03-23 | Reiterated Rating | Morgan Stanley | Hold | $54.00 |
| 2016-01-21 | Upgrade | KeyBanc | Sector Weight to Overweight | $59.00 |
| 2015-12-16 | Upgrade | Northcoast Research | Neutral to Buy | |
| 2015-09-23 | Initiated Coverage | Goldman Sachs | Neutral | $61.00 |
| 2015-04-06 | Upgrade | Bank of America | Neutral to Buy | $48.73 to $57.00 |
| 2015-01-07 | Upgrade | Bank of America | Underperform to Neutral | |
| 2015-01-05 | Upgrade | Morgan Stanley | Underweight to Equal Weight | |
| 2014-12-02 | Upgrade | Goldman Sachs | Buy to Conviction-Buy | $53.00 |
| 2014-11-06 | Reiterated Rating | Bank of America | Underperform | $43.00 to $48.00 |
| 2014-06-25 | Upgrade | Goldman Sachs | Neutral to Buy | |
| 2014-06-25 | Boost Price Target | Piper Jaffray | $40.00 to $43.00 | |
| 2014-05-02 | Reiterated Rating | Morgan Stanley | Underweight | $36.00 |
| 2014-04-11 | Downgrade | Northcoast Research | Buy to Neutral | |
| 2014-04-09 | Initiated Coverage | KeyBanc | Hold | |
| 2014-02-10 | Downgrade | Ned Davis Research | Buy to Neutral | |
| 2014-01-24 | Lower Price Target | Piper Jaffray | Neutral | $44.00 to $40.00 |
| 2013-11-11 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $36.00 |
| 2013-10-25 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
| 2013-10-25 | Downgrade | Wells Fargo | Outperform to Market Perform | |
| 2013-09-16 | Initiated Coverage | Sidoti | Neutral | |
| 2012-07-27 | Downgrade | Hilliard Lyons | Buy to Long-term Buy | $35 |
| 2011-08-05 | Upgrade | Hilliard Lyons | Neutral to Buy | $40 |
| 2011-07-29 | Upgrade | Morgan Keegan | Mkt Perform to Outperform | $48 to $45 |
| 2010-04-30 | Downgrade | Hilliard Lyons | Long-term Buy to Neutral | |
| 2008-12-16 | Downgrade | Oppenheimer | Outperform to Perform | |
| 2008-06-11 | Downgrade | Soleil | Hold to Sell | $27 to $25 |
| 2008-05-02 | Initiated | Oppenheimer | Outperform | $35 |
| 2016-06-23 | Reiterated Rating | KeyBanc | Buy | $59.00 |
| 2016-06-23 | Reiterated Rating | KeyCorp | Buy | $59.00 |
| 2016-06-16 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $54.00 to $62.00 |
| 2016-05-03 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-05-02 | Reiterated Rating | Bank of America | Buy | $69.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HRC 45 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 2.56M |
| BlackRock Institutional Trust Company, N.A. | 2.32M |
| FIRST INVESTORS MANAGEMENT CO INC | 0.36M |
| BlackRock Investment Management, LLC | 0.23M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.23M |
| RUSSELL FRANK CO/ | 0.19M |
| TEACHERS ADVISORS INC | 0.17M |
| PIONEER INVESTMENT MANAGEMENT INC | 0.14M |
| AHL Partners LLP | 0.12M |
| BlackRock Group LTD | 75940 |
| EverPoint Asset Management, LLC | 75000 |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 71111 |
| BOSTON ADVISORS LLC | 60411 |
| JANUS CAPITAL MANAGEMENT LLC | 60200 |
| Aperio Group, LLC | 49695 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| GREISCH JOHN J President and CEO | 0.40% (230851) | HRC / |
| HILLENBRAND W AUGUST | 0.24% (137632) | HI / HRC / |
| SHADER ALTON Sr VP & Pres Post Acute Care | 0.09% (50910) | HRC / |
| LICHTENSTEIN SUSAN R Sr. VP and CLO | 0.05% (27217) | AVIV / HRC / |
| FRANK ANDREAS G SVP Corp Develop & Strategy | 0.03% (19577) | HRC / |
| GUINAN MARK Sr. VP & CFO | 0.03% (19036) | DGX / HRC / |
| CLASSON ROLF A | 0.03% (15806) | AUXL / CTLT / ENZN / HRC / PRGO / |
| STROBEL STEVEN J Senior Vice President and CFO | 0.02% (13891) | HRC / NWL / |
| Saracho Alejandro Infante President, International | 0.02% (13876) | HRC / |
| Meyers Kenneth F Senior VP Chief HR Officer | 0.02% (12361) | HRC / HSP / INCR / |
| Keller Richard G VP, Controller & CAO | 0.02% (11812) | HRC / |
| Rasin Deborah Sr. VP and CLO | 0.02% (10233) | HRC / XRAY / |
| PRITCHARD EDWARD GREGORY SVP & Pres Surg. Resp. | 0.01% (7500) | HRC / |
| Golden Charles E | 0.01% (6464) | ETN / HRC / |
| Jeffers Scott R. Sr. VP, Global Supply Chain | 0.01% (5418) | HRC / |
| ALONSO-MARUM CARLOS SVP, President International | 0.01% (3543) | HRC / |
| Macek Michael S. VP, Treasurer and Interim CFO | 0.01% (3024) | HRC / |
UM